Sabin Receives Additional $21.8 Million from BARDA to Advance Marburg Vaccine

WASHINGTON, Sept. 14 (Korea Bizwire) — The Sabin Vaccine Institute today announced it is receiving an additional $21.8 million under an existing contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response at the U.S. Department of Health and Human Services. These funds advance development of [...]